{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:47:59Z","timestamp":1794466079172,"version":"4.9.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41584-020-0409-1","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T12:36:47Z","timestamp":1587991007000},"page":"301-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":183,"title":["PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-0437","authenticated-orcid":false,"given":"Ashley M.","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-0279","authenticated-orcid":false,"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"409_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0005-2795(77)90250-1","volume":"495","author":"GE Rogers","year":"1977","unstructured":"Rogers, G. E., Harding, H. W. J. & Llewellyn-Smith, I. J. The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichohyalin, an intracellular precursor. Biochim. Biophys. Acta 495, 159\u2013175 (1977).","journal-title":"Biochim. Biophys. Acta"},{"key":"409_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/oxfordjournals.jbchem.a133189","volume":"89","author":"M Fujisaki","year":"1981","unstructured":"Fujisaki, M. & Sugawara, K. Properties of peptidylarginine deiminase from the epidermis of newborn rats. J. Biochem. 89, 257\u2013263 (1981).","journal-title":"J. Biochem."},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"49562","DOI":"10.1074\/jbc.M208795200","volume":"277","author":"K Nakashima","year":"2002","unstructured":"Nakashima, K., Hagiwara, T. & Yamada, M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J. Biol. Chem. 277, 49562\u201349568 (2002).","journal-title":"J. Biol. Chem."},{"key":"409_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar, E. R., Zendman, A. J. W., Venrooij, W. J. van & Pruijn, G. J. M. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106\u20131118 (2003).","journal-title":"Bioessays"},{"key":"409_CR5","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1074\/mcp.RA118.000696","volume":"17","author":"C-Y Lee","year":"2018","unstructured":"Lee, C.-Y. et al. Mining the human tissue proteome for protein citrullination. Mol. Cell. Proteom. 17, 1378\u20131391 (2018).","journal-title":"Mol. Cell. Proteom."},{"key":"409_CR6","unstructured":"Amin, B. & Voelter, W. in Progress in the Chemistry of Organic Natural Products 106 (eds Kinghorn, A. D., Falk, H., Gibbons, S. & Kobayashi, J.) 203\u2013240 (Springer International Publishing, 2017)."},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng1206","volume":"34","author":"A Suzuki","year":"2003","unstructured":"Suzuki, A. et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395\u2013402 (2003).","journal-title":"Nat. Genet."},{"key":"409_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/ard.2003.012211","volume":"63","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63, 373\u2013381 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/art.30235","volume":"63","author":"J Freudenberg","year":"2011","unstructured":"Freudenberg, J. et al. Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci. Arthritis Rheum. 63, 884\u2013893 (2011).","journal-title":"Arthritis Rheum."},{"key":"409_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1055-2","volume":"17","author":"A Suzuki","year":"2016","unstructured":"Suzuki, A. et al. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice. BMC Musculoskelet. Disord. 17, 205 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"409_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.01.006","volume":"80","author":"M Bawadekar","year":"2017","unstructured":"Bawadekar, M. et al. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. J. Autoimmun. 80, 1\u20139 (2017).","journal-title":"J. Autoimmun."},{"key":"409_CR12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1189\/jlb.70.1.46","volume":"70","author":"H Asaga","year":"2001","unstructured":"Asaga, H., Nakashima, K., Senshu, T., Ishigami, A. & Yamada, M. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J. Leukoc. Biol. 70, 46\u201351 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"409_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1083\/jcb.200806072","volume":"184","author":"Y Wang","year":"2009","unstructured":"Wang, Y. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205\u2013213 (2009).","journal-title":"J. Cell Biol."},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"409_CR16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3389\/fimmu.2017.01200","volume":"8","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. Spontaneous secretion of the citrullination enzyme PAD2 and cell surface exposure of PAD4 by neutrophils. Front. Immunol. 8, 1200 (2017).","journal-title":"Front. Immunol."},{"key":"409_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature12942","volume":"506","author":"MA Christophorou","year":"2014","unstructured":"Christophorou, M. A. et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 506, 104 (2014).","journal-title":"Nature"},{"key":"409_CR18","doi-asserted-by":"publisher","first-page":"eaal3062","DOI":"10.1126\/sciimmunol.aal3062","volume":"2","author":"B Sun","year":"2017","unstructured":"Sun, B. et al. Citrullination of NF-\u03baB p65 promotes its nuclear localization and TLR-induced expression of IL-1\u03b2 and TNF\u03b1. Sci. Immunol. 2, eaal3062 (2017).","journal-title":"Sci. Immunol."},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1128\/MCB.01747-07","volume":"28","author":"P Li","year":"2008","unstructured":"Li, P. et al. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol. Cell. Biol. 28, 4745\u20134758 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"17069","DOI":"10.1074\/jbc.M111.230961","volume":"286","author":"Q Guo","year":"2011","unstructured":"Guo, Q. & Fast, W. Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. J. Biol. Chem. 286, 17069\u201317078 (2011).","journal-title":"J. Biol. Chem."},{"key":"409_CR21","doi-asserted-by":"publisher","first-page":"13331","DOI":"10.1073\/pnas.1203280109","volume":"109","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor target gene activation. Proc. Natl Acad. Sci. USA 109, 13331\u201313336 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273\u2013281 (1998).","journal-title":"J. Clin. Invest."},{"key":"409_CR23","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"409_CR24","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4\u2010Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist, S. et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48, 2741\u20132749 (2003).","journal-title":"Arthritis Rheum."},{"key":"409_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove, J. et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7, e35296 (2012).","journal-title":"PLoS One"},{"key":"409_CR26","first-page":"R958","volume":"7","author":"AHM van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil, A. H. M., Verpoort, K. N., Breedveld, F. C., Toes, R. E. M. & Huizinga, T. W. J. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res. Ther. 7, R958 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2007","unstructured":"Machold, K. P. et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology 46, 342\u2013349 (2007).","journal-title":"Rheumatology"},{"key":"409_CR28","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00296-009-0870-2","volume":"29","author":"X Chang","year":"2009","unstructured":"Chang, X., Zhao, Y., Sun, S., Zhang, Y. & Zhu, Y. The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol. Int. 29, 1411\u20131416 (2009).","journal-title":"Rheumatol. Int."},{"key":"409_CR29","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.23618","volume":"58","author":"A Kinloch","year":"2008","unstructured":"Kinloch, A. et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 58, 2287\u20132295 (2008).","journal-title":"Arthritis Rheum."},{"key":"409_CR30","doi-asserted-by":"publisher","first-page":"10746","DOI":"10.1073\/pnas.95.18.10746","volume":"95","author":"F Corn\u00e9lis","year":"1998","unstructured":"Corn\u00e9lis, F. et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl Acad. Sci. USA 95, 10746\u201310750 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"409_CR31","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/intimm\/10.12.1891","volume":"10","author":"S Shiozawa","year":"1998","unstructured":"Shiozawa, S. et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int. Immunol. 10, 1891\u20131895 (1998).","journal-title":"Int. Immunol."},{"key":"409_CR32","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","volume":"186","author":"VC Willis","year":"2011","unstructured":"Willis, V. C. et al. N-\u03b1-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J. Immunol. 186, 4396\u20134404 (2011).","journal-title":"J. Immunol."},{"key":"409_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cei.12932","volume":"188","author":"VC Willis","year":"2017","unstructured":"Willis, V. C. et al. Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis. Clin. Exp. Immunol. 188, 263\u2013274 (2017).","journal-title":"Clin. Exp. Immunol."},{"key":"409_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep26430","volume":"6","author":"J Kawalkowska","year":"2016","unstructured":"Kawalkowska, J. et al. Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses. Sci. Rep. 6, 26430 (2016).","journal-title":"Sci. Rep."},{"key":"409_CR35","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/art.38393","volume":"66","author":"MA Shelef","year":"2014","unstructured":"Shelef, M. A. et al. Peptidylarginine deiminase 4 contributes to tumor necrosis factor \u03b1-induced inflammatory arthritis. Arthritis Rheumatol. 66, 1482\u20131491 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep13041","volume":"5","author":"Y Seri","year":"2015","unstructured":"Seri, Y. et al. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci. Rep. 5, 13041 (2015).","journal-title":"Sci. Rep."},{"key":"409_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1399-0039.2008.01119.x","volume":"72","author":"LY Fan","year":"2008","unstructured":"Fan, L. Y. et al. A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. Tissue Antigens 72, 469\u2013473 (2008).","journal-title":"Tissue Antigens"},{"key":"409_CR38","doi-asserted-by":"publisher","first-page":"R250","DOI":"10.1186\/ar4093","volume":"14","author":"CL Too","year":"2012","unstructured":"Too, C. L. et al. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. Arthritis Res. Ther. 14, R250 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR39","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/ar1889","volume":"8","author":"B Hoppe","year":"2006","unstructured":"Hoppe, B. et al. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res. Ther. 8, R34 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR40","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.20169","volume":"50","author":"A Barton","year":"2004","unstructured":"Barton, A. et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50, 1117\u20131121 (2004).","journal-title":"Arthritis Rheum."},{"key":"409_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.2004.026831","volume":"64","author":"L Caponi","year":"2005","unstructured":"Caponi, L. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann. Rheum. Dis. 64, 587\u2013593 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR42","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1093\/hmg\/ddr161","volume":"20","author":"C Terao","year":"2011","unstructured":"Terao, C. et al. The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population. Hum. Mol. Genet. 20, 2680\u20132685 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"409_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381 (2014).","journal-title":"Nature"},{"key":"409_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8545","volume":"6","author":"V Naranbhai","year":"2015","unstructured":"Naranbhai, V. et al. Genomic modulators of gene expression in human neutrophils. Nat. Commun. 6, 7545 (2015).","journal-title":"Nat. Commun."},{"key":"409_CR45","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.3390\/ijms20123093","volume":"20","author":"AM Mergaert","year":"2019","unstructured":"Mergaert, A. M. et al. Reduced anti-histone antibodies and increased risk of rheumatoid arthritis associated with a single nucleotide polymorphism in PADI4 in North Americans. Int. J. Mol. Sci. 20, 3093 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"409_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081259","volume":"8","author":"X Chang","year":"2013","unstructured":"Chang, X. et al. PADI2 is significantly associated with rheumatoid arthritis. PLoS One 8, e81259 (2013).","journal-title":"PLoS One"},{"key":"409_CR47","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessi\u00e8re","year":"2001","unstructured":"Masson-Bessi\u00e8re, C. et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 166, 4177\u20134184 (2001).","journal-title":"J. Immunol."},{"key":"409_CR48","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res. Ther. 6, R142 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR49","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/ard.2008.091355","volume":"68","author":"O Snir","year":"2009","unstructured":"Snir, O. et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann. Rheum. Dis. 68, 736\u2013743 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203214","volume":"13","author":"D Damgaard","year":"2018","unstructured":"Damgaard, D. et al. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3. PLoS One 13, e0203214 (2018).","journal-title":"PLoS One"},{"key":"409_CR51","doi-asserted-by":"publisher","first-page":"103484","DOI":"10.1016\/j.jprot.2019.103484","volume":"208","author":"M Sharma","year":"2019","unstructured":"Sharma, M. et al. Expanding the citrullinome of synovial fibrinogen from rheumatoid arthritis patients. J. Proteom. 208, 103484 (2019).","journal-title":"J. Proteom."},{"key":"409_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/ard.2011.151712","volume":"71","author":"E Darrah","year":"2012","unstructured":"Darrah, E., Rosen, A., Giles, J. T. & Andrade, F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann. Rheum. Dis. 71, 92\u201398 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR53","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1039\/c1mb05089c","volume":"7","author":"Q Guo","year":"2011","unstructured":"Guo, Q., Bedford, M. T. & Fast, W. Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2. Mol. Biosyst. 7, 2286\u20132295 (2011).","journal-title":"Mol. Biosyst."},{"key":"409_CR54","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.bbapap.2014.02.019","volume":"1844","author":"C Assohou-Luty","year":"2014","unstructured":"Assohou-Luty, C. et al. The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities. Biochim. Biophys. Acta 1844, 829\u2013836 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"409_CR55","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/art.40035","volume":"69","author":"NE Blach\u00e8re","year":"2017","unstructured":"Blach\u00e8re, N. E. et al. High-titer rheumatoid arthritis antibodies preferentially bind fibrinogen citrullinated by peptidylarginine deiminase 4. Arthritis Rheumatol. 69, 986\u2013995 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-016-1068-0","volume":"18","author":"M Bawadekar","year":"2016","unstructured":"Bawadekar, M. et al. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation. Arthritis Res. Ther. 18, 173 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR57","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s13075-014-0498-9","volume":"16","author":"D Damgaard","year":"2014","unstructured":"Damgaard, D., Senolt, L., Nielsen, M. F., Pruijn, G. J. & Nielsen, C. H. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Arthritis Res. Ther. 16, 498 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR58","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/rheumatology\/kev440","volume":"55","author":"D Damgaard","year":"2016","unstructured":"Damgaard, D., Senolt, L. & Nielsen, C. H. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: association with disease activity and inflammatory markers. Rheumatology 55, 918\u2013927 (2016).","journal-title":"Rheumatology"},{"key":"409_CR59","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/art.20296","volume":"50","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. et al. Absence of citrulline-specific autoantibodies in animal models of autoimmunity. Arthritis Rheum. 50, 2370\u20132372 (2004).","journal-title":"Arthritis Rheum."},{"key":"409_CR60","doi-asserted-by":"publisher","first-page":"129687","DOI":"10.1172\/jci.insight.129687","volume":"4","author":"B Sun","year":"2019","unstructured":"Sun, B. et al. Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination. JCI Insight 4, 129687 (2019).","journal-title":"JCI Insight"},{"key":"409_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/03009740410004990","volume":"32","author":"R Nissinen","year":"2003","unstructured":"Nissinen, R. et al. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren syndrome. Scand. J. Rheumatol. 32, 337\u2013342 (2003).","journal-title":"Scand. J. Rheumatol."},{"key":"409_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/ar464","volume":"4","author":"ER Vossenaar","year":"2002","unstructured":"Vossenaar, E. R. et al. Expression of PAD enzymes and occurrence of citrulline-containing proteins in human blood and synovial fluid cells. Arthritis Res. Ther. 4, 24 (2002).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR63","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res."},{"key":"409_CR64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/03009740510026346-1","volume":"34","author":"Y Takizawa","year":"2005","unstructured":"Takizawa, Y. et al. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand. J. Rheumatol. 34, 212\u2013215 (2005).","journal-title":"Scand. J. Rheumatol."},{"key":"409_CR65","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2007.080267","volume":"67","author":"EH Halvorsen","year":"2008","unstructured":"Halvorsen, E. H. et al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann. Rheum. Dis. 67, 414\u2013417 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR66","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/art.23596","volume":"58","author":"ML Harris","year":"2008","unstructured":"Harris, M. L. et al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum. 58, 1958\u20131967 (2008).","journal-title":"Arthritis Rheum."},{"key":"409_CR67","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.27570","volume":"62","author":"JR Kolfenbach","year":"2010","unstructured":"Kolfenbach, J. R. et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum. 62, 2633\u20132639 (2010).","journal-title":"Arthritis Rheum."},{"key":"409_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cei.12677","volume":"182","author":"Z Reyes-Castillo","year":"2015","unstructured":"Reyes-Castillo, Z. et al. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin. Exp. Immunol. 182, 119\u2013131 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"409_CR69","first-page":"969","volume":"35","author":"J Zhao","year":"2008","unstructured":"Zhao, J., Zhao, Y., He, J., Jia, R. & Li, Z. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J. Rheumatol. 35, 969\u2013974 (2008).","journal-title":"J. Rheumatol."},{"key":"409_CR70","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3899\/jrheum.170769","volume":"45","author":"K Guderud","year":"2018","unstructured":"Guderud, K. et al. Lack of association among peptidyl arginine deiminase type 4 autoantibodies, PADI4 polymorphisms, and clinical characteristics in rheumatoid arthritis. J. Rheumatol. 45, 1211\u20131219 (2018).","journal-title":"J. Rheumatol."},{"key":"409_CR71","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/annrheumdis-2018-213818","volume":"78","author":"L Martinez-Prat","year":"2019","unstructured":"Martinez-Prat, L., Lucia, D., Ibarra, C., Mahler, M. & Dervieux, T. Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis. Ann. Rheumatic Dis. 78, 434\u2013436 (2019).","journal-title":"Ann. Rheumatic Dis."},{"key":"409_CR72","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/annrheumdis-2017-211782","volume":"77","author":"J R\u00f6nnelid","year":"2018","unstructured":"R\u00f6nnelid, J. et al. Anticitrullinated protein\/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants. Ann. Rheumatic Dis. 77, 203\u2013211 (2018).","journal-title":"Ann. Rheumatic Dis."},{"key":"409_CR73","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar2011","volume":"8","author":"B Vander Cruyssen","year":"2006","unstructured":"Vander Cruyssen, B. et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res. Ther. 8, R122 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR74","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","volume":"53","author":"D Coenen","year":"2007","unstructured":"Coenen, D., Verschueren, P., Westhovens, R. & Bossuyt, X. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin. Chem. 53, 498\u2013504 (2007).","journal-title":"Clin. Chem."},{"key":"409_CR75","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/annrheumdis-2012-202535","volume":"73","author":"BA Fisher","year":"2014","unstructured":"Fisher, B. A. et al. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease. Ann. Rheumatic Dis. 73, 741\u2013747 (2014).","journal-title":"Ann. Rheumatic Dis."},{"key":"409_CR76","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/ard.2008.094490","volume":"68","author":"EH Halvorsen","year":"2009","unstructured":"Halvorsen, E. H. et al. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann. Rheumatic Dis. 68, 249\u2013252 (2009).","journal-title":"Ann. Rheumatic Dis."},{"key":"409_CR77","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-016-1126-7","volume":"18","author":"I Navarro-Mill\u00e1n","year":"2016","unstructured":"Navarro-Mill\u00e1n, I. et al. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans. Arthritis Res. Ther. 18, 241 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR78","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/art.40791","volume":"71","author":"E Darrah","year":"2019","unstructured":"Darrah, E. et al. Association of baseline peptidylarginine deiminase 4 autoantibodies with favorable response to treatment escalation in rheumatoid arthritis. Arthritis Rheumatol. 71, 696\u2013702 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR79","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3899\/jrheum.130293","volume":"40","author":"ED Ferucci","year":"2013","unstructured":"Ferucci, E. D. et al. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American populations. J. Rheumatol. 40, 1523\u20131528 (2013).","journal-title":"J. Rheumatol."},{"key":"409_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13075-018-1533-z","volume":"20","author":"LC Cappelli","year":"2018","unstructured":"Cappelli, L. C., Konig, M. F., Gelber, A. C., Bingham, C. O. & Darrah, E. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis. Arthritis Res. Ther. 20, 59 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR81","doi-asserted-by":"publisher","first-page":"186ra65","DOI":"10.1126\/scitranslmed.3005370","volume":"5","author":"E Darrah","year":"2013","unstructured":"Darrah, E. et al. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci. Transl Med. 5, 186ra65 (2013).","journal-title":"Sci. Transl Med."},{"key":"409_CR82","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/oxfordjournals.jbchem.a123636","volume":"110","author":"H Terakawa","year":"1991","unstructured":"Terakawa, H., Takahara, H. & Sugawara, K. Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. J. Biochem. 110, 661\u2013666 (1991).","journal-title":"J. Biochem."},{"key":"409_CR83","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2017-211489","volume":"77","author":"J Shi","year":"2018","unstructured":"Shi, J. et al. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis. Ann. Rheum. Dis. 77, 141\u2013148 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098794","volume":"9","author":"JT Giles","year":"2014","unstructured":"Giles, J. T. et al. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease. PLoS One 9, e98794 (2014).","journal-title":"PLoS One"},{"key":"409_CR85","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3389\/fimmu.2018.02696","volume":"9","author":"E Darrah","year":"2018","unstructured":"Darrah, E. et al. Autoantibodies to peptidylarginine deiminase 2 are associated with less severe disease in rheumatoid arthritis. Front. Immunol. 9, 2696 (2018).","journal-title":"Front. Immunol."},{"key":"409_CR86","first-page":"12","volume":"24","author":"EB Roth","year":"2006","unstructured":"Roth, E. B., Stenberg, P., Book, C. & Sj\u00f6berg, K. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis \u2014 new pathways to epitope spreading. Clin. Exp. Rheumatol. 24, 12\u201318 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"409_CR87","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1021\/acs.jproteome.6b00617","volume":"16","author":"E Darrah","year":"2017","unstructured":"Darrah, E. et al. Proteolysis by granzyme B enhances presentation of autoantigenic peptidylarginine deiminase 4 epitopes in rheumatoid arthritis. J. Proteome Res. 16, 355\u2013365 (2017).","journal-title":"J. Proteome Res."},{"key":"409_CR88","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/BOR.0b013e328336ba63","volume":"22","author":"J Holoshitz","year":"2010","unstructured":"Holoshitz, J. The rheumatoid arthritis HLA\u2013DRB1 shared epitope. Curr. Opin. Rheumatol. 22, 293\u2013298 (2010).","journal-title":"Curr. Opin. Rheumatol."},{"key":"409_CR89","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2012.134","volume":"8","author":"WP Arend","year":"2012","unstructured":"Arend, W. P. & Firestein, G. S. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat. Rev. Rheumatol. 8, 573\u2013586 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"409_CR90","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10067-015-3082-z","volume":"35","author":"N Umeda","year":"2016","unstructured":"Umeda, N. et al. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases. Clin. Rheumatol. 35, 1181\u20131188 (2016).","journal-title":"Clin. Rheumatol."},{"key":"409_CR91","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/ar2131","volume":"9","author":"P-A Gourraud","year":"2007","unstructured":"Gourraud, P.-A. et al. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis. Arthritis Res. Ther. 9, R27 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"409_CR92","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000099","volume":"1","author":"A Ruyssen-Witrand","year":"2015","unstructured":"Ruyssen-Witrand, A. et al. A new classification of HLA-DRB1 alleles based on acid\u2013base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort). RMD Open 1, e000099 (2015).","journal-title":"RMD Open"},{"key":"409_CR93","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt, P. et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 62, 835\u2013841 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR94","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog, L. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54, 38\u201346 (2006).","journal-title":"Arthritis Rheum."},{"key":"409_CR95","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/art.40852","volume":"71","author":"AK Hedstr\u00f6m","year":"2019","unstructured":"Hedstr\u00f6m, A. K., R\u00f6nnelid, J., Klareskog, L. & Alfredsson, L. Complex relationships of smoking, HLA-DRB1 genes, and serologic profiles in patients with early rheumatoid arthritis: update from a Swedish population-based case\u2013control study. Arthritis Rheumatol. 71, 1504\u20131511 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR96","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/RHU.0000000000000619","volume":"24","author":"A Polachek","year":"2018","unstructured":"Polachek, A. et al. Sputum anticitrullinated protein antibodies in patients with long-standing rheumatoid arthritis. J. Clin. Rheumatol. 24, 122\u2013126 (2018).","journal-title":"J. Clin. Rheumatol."},{"key":"409_CR97","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","volume":"65","author":"VC Willis","year":"2013","unstructured":"Willis, V. C. et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 65, 2545\u20132554 (2013).","journal-title":"Arthritis Rheum."},{"key":"409_CR98","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/art.40401","volume":"70","author":"MK Demoruelle","year":"2018","unstructured":"Demoruelle, M. K. et al. Antibody responses to citrullinated and noncitrullinated antigens in the sputum of subjects with rheumatoid arthritis and subjects at risk for development of rheumatoid arthritis. Arthritis Rheumatol. 70, 516\u2013527 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR99","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/art.40066","volume":"69","author":"MK Demoruelle","year":"2017","unstructured":"Demoruelle, M. K. et al. Anti-citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients. Arthritis Rheumatol. 69, 1165\u20131175 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR100","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","volume":"14","author":"VM Holers","year":"2018","unstructured":"Holers, V. M. et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat. Rev. Rheumatol. 14, 542\u2013557 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"409_CR101","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrrheum.2017.132","volume":"13","author":"J Potempa","year":"2017","unstructured":"Potempa, J., Mydel, P. & Koziel, J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat. Rev. Rheumatol. 13, 606\u2013620 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"409_CR102","doi-asserted-by":"publisher","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","volume":"8","author":"MF Konig","year":"2016","unstructured":"Konig, M. F. et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci. Transl Med. 8, 369ra176 (2016).","journal-title":"Sci. Transl Med."},{"key":"409_CR103","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/jcm8091309","volume":"8","author":"E G\u00f3mez-Ba\u00f1uelos","year":"2019","unstructured":"G\u00f3mez-Ba\u00f1uelos, E., Mukherjee, A., Darrah, E. & Andrade, F. Rheumatoid arthritis-associated mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J. Clin. Med. 8, 1309 (2019).","journal-title":"J. Clin. Med."},{"key":"409_CR104","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1002\/art.27552","volume":"62","author":"N Wegner","year":"2010","unstructured":"Wegner, N. et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and \u03b1-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62, 2662\u20132672 (2010).","journal-title":"Arthritis Rheum."},{"key":"409_CR105","doi-asserted-by":"publisher","first-page":"209ra150","DOI":"10.1126\/scitranslmed.3006869","volume":"5","author":"V Romero","year":"2013","unstructured":"Romero, V. et al. Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci. Transl Med. 5, 209ra150 (2013).","journal-title":"Sci. Transl Med."},{"key":"409_CR106","first-page":"461","volume":"7","author":"MF Konig","year":"2016","unstructured":"Konig, M. F. & Andrade, F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front. Immunol. 7, 461 (2016).","journal-title":"Front. Immunol."},{"key":"409_CR107","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/art.39313","volume":"67","author":"J Spengler","year":"2015","unstructured":"Spengler, J. et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol. 67, 3135\u20133145 (2015).","journal-title":"Arthritis Rheumatol."},{"issue":"suppl 10","key":"409_CR108","first-page":"2902","volume":"70","author":"P Naik","year":"2018","unstructured":"Naik, P., Shi, J., Andrade, F. & Darrah, E. Antibodies to PAD4 drive monocyte activation and differentiation into osteoclast-like cells [abstract]. Arthritis Rheumatol. 70 (suppl 10), 2902 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR109","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1046\/j.1365-2249.1999.00881.x","volume":"116","author":"PP Tak","year":"1999","unstructured":"Tak, P. P. et al. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 116, 366\u2013370 (1999).","journal-title":"Clin. Exp. Immunol."},{"key":"409_CR110","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/cdd.2009.197","volume":"17","author":"E Darrah","year":"2010","unstructured":"Darrah, E. & Rosen, A. Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ. 17, 624\u2013632 (2010).","journal-title":"Cell Death Differ."},{"key":"409_CR111","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/art.27439","volume":"62","author":"F Andrade","year":"2010","unstructured":"Andrade, F. et al. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum. 62, 1630\u20131640 (2010).","journal-title":"Arthritis Rheum."},{"key":"409_CR112","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1021\/bi200309e","volume":"50","author":"JL Slack","year":"2011","unstructured":"Slack, J. L., Jones, L. E. Jr., Bhatia, M. M. & Thompson, P. R. Autodeimination of protein arginine deiminase 4 alters protein\u2013protein interactions but not activity. Biochemistry 50, 3997\u20134010 (2011).","journal-title":"Biochemistry"},{"key":"409_CR113","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00018-010-0262-5","volume":"67","author":"M-C M\u00e9chin","year":"2010","unstructured":"M\u00e9chin, M.-C. et al. Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases. Cell. Mol. Life Sci. 67, 1491\u20131503 (2010).","journal-title":"Cell. Mol. Life Sci."},{"key":"409_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/art.41276","author":"E Darrah","year":"2020","unstructured":"Darrah, E. et al. Citrullination is not a major determinant in the recognition of peptidylarginine deiminase 2 and 4 by autoantibodies in rheumatoid arthritis. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.41276 (2020)","journal-title":"Arthritis Rheumatol."},{"key":"409_CR115","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.27230","volume":"62","author":"I Auger","year":"2010","unstructured":"Auger, I., Martin, M., Balandraud, N. & Roudier, J. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. Arthritis Rheum. 62, 126\u2013131 (2010).","journal-title":"Arthritis Rheum."},{"key":"409_CR116","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3, 797\u2013801 (1997).","journal-title":"Nat. Med."},{"key":"409_CR117","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.coi.2011.08.006","volume":"23","author":"LM Sollid","year":"2011","unstructured":"Sollid, L. M. & Jabri, B. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr. Opin. Immunol. 23, 732\u2013738 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"409_CR118","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2018.04.004","volume":"92","author":"J Pieper","year":"2018","unstructured":"Pieper, J. et al. Memory T cells specific to citrullinated \u03b1-enolase are enriched in the rheumatic joint. J. Autoimmun. 92, 47\u201356 (2018).","journal-title":"J. Autoimmun."},{"key":"409_CR119","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.40768","volume":"71","author":"C Rims","year":"2019","unstructured":"Rims, C. et al. Citrullinated aggrecan epitopes as targets of autoreactive CD4+ T cells in patients with rheumatoid arthritis. Arthritis Rheumatol. 71, 518\u2013528 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"409_CR120","doi-asserted-by":"publisher","first-page":"E10177","DOI":"10.1073\/pnas.1713112114","volume":"114","author":"F Arnoux","year":"2017","unstructured":"Arnoux, F. et al. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types. Proc. Natl Acad. Sci. USA 114, E10177 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"409_CR121","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.30081","volume":"63","author":"J Sokolove","year":"2011","unstructured":"Sokolove, J., Zhao, X., Chandra, P. E. & Robinson, W. H. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor. Arthritis Rheum. 63, 53\u201362 (2011).","journal-title":"Arthritis Rheum."},{"key":"409_CR122","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791\u20131802 (2012).","journal-title":"J. Clin. Invest."},{"key":"409_CR123","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.4049\/jimmunol.1800534","volume":"202","author":"A Krishnamurthy","year":"2019","unstructured":"Krishnamurthy, A. et al. Citrullination controls dendritic cell transdifferentiation into osteoclasts. J. Immunol. 202, 3143\u20133150 (2019).","journal-title":"J. Immunol."},{"key":"409_CR124","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","volume":"75","author":"G Wigerblad","year":"2016","unstructured":"Wigerblad, G. et al. Autoantibodies to citrullinated proteins may induce joint pain independent of inflammation. Ann. Rheum. Dis. 75, 730\u2013738 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR125","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/art.24622","volume":"60","author":"LA Trouw","year":"2009","unstructured":"Trouw, L. A. et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 60, 1923\u20131931 (2009).","journal-title":"Arthritis Rheum."},{"key":"409_CR126","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","volume":"8","author":"A Willemze","year":"2012","unstructured":"Willemze, A., Trouw, L. A., Toes, R. E. M. & Huizinga, T. W. J. The influence of ACPA status and characteristics on the course of RA. Nat. Rev. Rheumatol. 8, 144\u2013152 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"409_CR127","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/jbmr.3158","volume":"32","author":"C Engdahl","year":"2017","unstructured":"Engdahl, C. et al. Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin. J. Bone Miner. Res. 32, 1681\u20131691 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"409_CR128","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","volume":"75","author":"A Krishnamurthy","year":"2016","unstructured":"Krishnamurthy, A. et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann. Rheum. Dis. 75, 721\u2013729 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"409_CR129","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00296-010-1765-y","volume":"32","author":"S Pollmann","year":"2012","unstructured":"Pollmann, S. et al. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate. Rheumatol. Int. 32, 1271\u20131276 (2012).","journal-title":"Rheumatol. Int."},{"key":"409_CR130","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/03009742.2019.1641216","volume":"49","author":"MK Jonsson","year":"2019","unstructured":"Jonsson, M. K. et al. Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis. Scand. J. Rheumatol. 49, 87\u201395 (2019).","journal-title":"Scand. J. Rheumatol."},{"key":"409_CR131","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1389450116666150202160954","volume":"16","author":"EE Witalison","year":"2015","unstructured":"Witalison, E. E., Thompson, P. R. & Hofseth, L. J. Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation. Curr. Drug. Targets 16, 700\u2013710 (2015).","journal-title":"Curr. Drug. Targets"},{"key":"409_CR132","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","volume":"353","author":"CT Ellebrecht","year":"2016","unstructured":"Ellebrecht, C. T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353, 179\u2013184 (2016).","journal-title":"Science"},{"key":"409_CR133","doi-asserted-by":"publisher","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","volume":"7","author":"H Benham","year":"2015","unstructured":"Benham, H. et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl Med. 7, 290ra87 (2015).","journal-title":"Sci. Transl Med."},{"key":"409_CR134","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1006\/bbrc.1996.1240","volume":"225","author":"T Senshu","year":"1996","unstructured":"Senshu, T., Kan, S., Ogawa, H., Manabe, M. & Asaga, H. Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem. Biophys. Res. Commun. 225, 712\u2013719 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"409_CR135","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1523-1755.2005.00383.x","volume":"68","author":"D Feng","year":"2005","unstructured":"Feng, D. et al. Citrullination preferentially proceeds in glomerular Bowman\u2019s capsule and increases in obstructive nephropathy. Kidney Int. 68, 84\u201395 (2005).","journal-title":"Kidney Int."},{"key":"409_CR136","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/dneu.20578","volume":"68","author":"G Keilhoff","year":"2008","unstructured":"Keilhoff, G. et al. Expression pattern of peptidylarginine deiminase in rat and human Schwann cells. Dev. Neurobiol. 68, 101\u2013114 (2008).","journal-title":"Dev. Neurobiol."},{"key":"409_CR137","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124729","volume":"3","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight 3, e124729 (2018).","journal-title":"JCI Insight"},{"key":"409_CR138","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/labinvest.3700748","volume":"88","author":"DD Wood","year":"2008","unstructured":"Wood, D. D. et al. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab. Invest. 88, 354\u2013364 (2008).","journal-title":"Lab. Invest."},{"key":"409_CR139","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0304-3940(98)00947-1","volume":"260","author":"JD Keyser","year":"1999","unstructured":"Keyser, J. D., Schaaf, M. & Teelken, A. Peptidylarginine deiminase activity in postmortem white matter of patients with multiple sclerosis. Neurosci. Lett. 260, 74\u201376 (1999).","journal-title":"Neurosci. Lett."},{"key":"409_CR140","doi-asserted-by":"crossref","first-page":"18119","DOI":"10.1016\/S0021-9258(19)84685-9","volume":"264","author":"M Inagaki","year":"1989","unstructured":"Inagaki, M., Takahara, H., Nishi, Y., Sugawara, K. & Sato, C. Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J. Biol. Chem. 264, 18119\u201318127 (1989).","journal-title":"J. Biol. Chem."},{"key":"409_CR141","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jnr.20431","volume":"80","author":"A Ishigami","year":"2005","unstructured":"Ishigami, A. et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer\u2019s disease. J. Neurosci. Res. 80, 120\u2013128 (2005).","journal-title":"J. Neurosci. Res."},{"key":"409_CR142","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00401-009-0625-x","volume":"119","author":"B Jang","year":"2010","unstructured":"Jang, B. et al. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 119, 199\u2013210 (2010).","journal-title":"Acta Neuropathol."},{"key":"409_CR143","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.1523\/JNEUROSCI.3349-06.2006","volume":"26","author":"FG Mastronardi","year":"2006","unstructured":"Mastronardi, F. G. et al. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J. Neurosci. 26, 11387\u201311396 (2006).","journal-title":"J. Neurosci."},{"key":"409_CR144","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1006\/bbrc.2001.6303","volume":"290","author":"T Hagiwara","year":"2002","unstructured":"Hagiwara, T., Nakashima, K., Hirano, H., Senshu, T. & Yamada, M. Deimination of arginine residues in nucleophosmin\/B23 and histones in HL-60 granulocytes. Biochem. Biophys. Res. Commun. 290, 979\u2013983 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"409_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-40","volume":"9","author":"X Chang","year":"2009","unstructured":"Chang, X. et al. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 9, 40 (2009).","journal-title":"BMC Cancer"},{"key":"409_CR146","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0012-1606(02)00126-4","volume":"256","author":"PW Wright","year":"2003","unstructured":"Wright, P. W. et al. ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev. Biol. 256, 74\u201389 (2003).","journal-title":"Dev. Biol."},{"key":"409_CR147","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jmb.2007.01.054","volume":"367","author":"R Raijmakers","year":"2007","unstructured":"Raijmakers, R. et al. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J. Mol. Biol. 367, 1118\u20131129 (2007).","journal-title":"J. Mol. Biol."},{"key":"409_CR148","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2007.05.005","volume":"273","author":"G Esposito","year":"2007","unstructured":"Esposito, G. et al. Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol. Cell. Endocrinol. 273, 25\u201331 (2007).","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0409-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T15:29:50Z","timestamp":1722785390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":148,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-0409-1","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"12 March 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.D. and J.T.G. declare that they are authors on licensed patent no. 8,975,033 entitled \u201cHuman autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases\u201d. E.D. declares that she is an author on provisional patent no. 62\/481,158 entitled \u201cAnti-PAD2 antibody for treating and evaluating rheumatoid arthritis\u201d. E.D. has received grants from Bristol-Myers Squibb, Celgene and Pfizer, and personal fees from Celgene that are not related to this article. A.M.C. and P.N. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}